Category:2024-03 study showing production costs of diabetes medicines much lower than on market

Media in category "2024-03 study showing production costs of diabetes medicines much lower than on market"

The following 5 files are in this category, out of 5 total.

• 
  Cost-Based Estimated Generic Price Algorithm for Sodium-Glucose Cotransporter 2 Inhibitors (SGLT2Is) and Oral Semaglutide.png 1,956 × 1,279; 96 KB
  
• 
  Cost-Based Estimated Price Algorithm for Insulins and Injectable and Glucagonlike Peptide 1 Agonists (GLP1As).png 1,956 × 1,621; 133 KB
  
• 
  Costs of Insulin Treatment per Person per Year, With Estimated Sustainable Cost-Based Prices vs Current Market Prices, Including Cost of Injection Devices.png 2,158 × 913; 116 KB
  
• 
  Estimated Sustainable Cost-Based Prices, per Month.png 2,158 × 2,683; 293 KB
  
• 
  Lowest Market Prices and Cost-Based Prices ($ per Month).png 1,955 × 2,085; 210 KB